When using progranulin as a biomarker for sepsis and pneumonia, the diagnostic performance of this molecule is comparable to that of procalcitonin, and surpasses the other established biomarkers C-reactive protein and interleukin-6 with regard to sensitivity and specificity. This evidence concerns the gene IL6 and susceptibility to pneumonia measurement.